(AOF) – Transgene and its Swedish partner BioInvent announce the selection of their abstract (abstract) describing preclinical results obtained with BT-001, a co-developed oncolytic virus, for a poster presentation at the 2022 annual conference of the American Association for Cancer Research (AACR). The conference will be held face-to-face in New Orleans, LA, April 8-13, 2022.
AOF – LEARN MORE
Boost for French pharmacy
At the end of a recent CSIS, the French authorities announced an amount of credits (7 billion euros) never reached: 1.5 billion for hospital-university research, 2 billion for investment in health via bpi france , 1.5 billion in aid for the relocation of industrial projects, and 2 billion to strengthen investment in three sectors of the future (bioproduction, digital medicine, and pandemic preparedness). In addition, the annual growth in drug expenditure reimbursed by Medicare will be 2.4%, which should generate growth of at least 0.5% in the turnover of laboratories,
Above all, the normal drug marketing procedure will be accelerated (up to 500 days saved) if the medical benefit rendered is sufficient.